Capital World Investors’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-300,000	Closed	-$36.9M	–	553
2018 Q3	$36.9M	Sell	300,000 -358,000	-54%	-$44M	0.01%	405
2018 Q2	$64.6M	Sell	658,000 -30,000	-4%	-$2.95M	0.01%	341
2018 Q1	$57.1M	Hold	688,000	–	–	0.01%	352
2017 Q4	$53.4M	Hold	688,000	–	–	0.01%	348
2017 Q3	$42.2M	Hold	688,000	–	–	0.01%	369
2017 Q2	$31.6M	Sell	688,000 -175,000	-20%	-$8.05M	0.01%	379
2017 Q1	$37.4M	Sell	863,000 -325,000	-27%	-$14.1M	0.01%	373
2016 Q4	$46M	Sell	1,188,000 -293,000	-20%	-$11.3M	0.01%	351
2016 Q3	$75M	Hold	1,481,000	–	–	0.02%	302
2016 Q2	$67.3M	Hold	1,481,000	–	–	0.02%	309
2016 Q1	$58.6M	Buy	1,481,000 +238,500	+19%	+$9.43M	0.02%	320
2015 Q4	$70.3M	Hold	1,242,500	–	–	0.02%	311
2015 Q3	$49.4M	Sell	1,242,500 -170,200	-12%	-$6.77M	0.01%	346
2015 Q2	$67.5M	Sell	1,412,700 -52,500	-4%	-$2.51M	0.02%	332
2015 Q1	$58.2M	Buy	1,465,200 +315,000	+27%	+$12.5M	0.02%	350
2014 Q4	$25.7M	Hold	1,150,200	–	–	0.01%	426
2014 Q3	$18M	Hold	1,150,200	–	–	0.01%	440
2014 Q2	$17.1M	Hold	1,150,200	–	–	﹤0.01%	433
2014 Q1	$18.5M	Buy	1,150,200 +625,200	+119%	+$10.1M	0.01%	427
2013 Q4	$4.9M	Hold	525,000	–	–	﹤0.01%	471
2013 Q3	$5.94M	Buy	+525,000	New	+$5.94M	﹤0.01%	468